Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-25
1995-06-27
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548540, A61K 3140, C07D295185, C07D295192
Patent
active
054280540
ABSTRACT:
Non-peptidyl compounds characterized generally as .alpha.-succinamidoacyl aminodiols having a pyrrolidinyl-type group at the N-terminus are useful as renin inhibitors for the treatment of hypertension.
REFERENCES:
H. Umezawa, et al, The Journal of Antibiotics (Tokyo) 23, 259-262, (1970).
F. Gross, et al, Science, 175, p. 656, (1971).
J. Boger, et al, Nature, 303, pp. 81-84, (1983).
T. Kokubu, et al, Biochem. Biophys. Research Commun., 118, pp. 929-933, (1984).
Fehrentz, et al, FEBS Lett., 167, pp. 273-276, (1984).
G. Hanson, et al, Biochem. Biophys. Research Commun., 132, pp. 155-161, (1987).
G. Hanson, et al, Biochem. Biophys. Research Commun., 146, pp. 959-963, (1987).
G. Marshall, Federation Proceedings, 35, pp. 2494-2501 (1976).
J. Burton, et al, Proc. Natl. Acad. Sci. USA, 77, pp. 5476-5479, (1980).
Y. Suketa, et al, Biochemistry, 14, pp. 3188-3194, (1975).
J. Swales, Pharma. Ther., 7, pp. 173-201, (1979).
Kokubu, et al, Nature, 217, pp. 456-457, (1968).
Y. Matsushita, et al, The Journal of Antibiotics, 28, pp. 1016-1018, (1975).
J. Lazar, et al, Biochem. Pharma., 23, pp. 2776-2778, (1974).
R. Miller, et al, Biochem. Pharma., 21, pp. 2941-2944, (1972).
E. Haber, Clinical Science, 59, pp. 7s-19s, (1982).
D. Rich, et al, J. Org. Chem., 43, pp. 3624-3626, (1978).
D. Rich, et al, J. Med. Chem., 23, pp. 27-33, (1980).
E. Haber, Clin. and Exper. Hyper., A5(7&8), pp. 1193-1205, (1983).
Baran John S.
Hanson Gunnar J.
Brust Joseph Paul
G. D. Searle & Co.
Keane J. Timothy
LandOfFree
Pyurrolidinyl-terminated non-peptidyl .alpha.-succinamidoacyl am does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyurrolidinyl-terminated non-peptidyl .alpha.-succinamidoacyl am, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyurrolidinyl-terminated non-peptidyl .alpha.-succinamidoacyl am will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287870